Tag: anti-inflammatory medicine

FDA, Regulations

Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia

November 11, 2022


Kineret is an anti-inflammatory medicine that neutralises the biological activity of both cytokines IL-1α and β, which play a role in COVID19-induced hyperinflammation. Blocking these cytokines early in the course of the hyperinflammatory phase can have an important impact on […]